
Sign up to save your podcasts
Or


In this episode, we explore evidence-based strategies for augmenting lithium when monotherapy fails in acute mania. Why is quetiapine the preferred add-on to valproate, despite decades of clinical tradition favoring anticonvulsants?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.
By Psychopharmacology Institute4.6
271271 ratings
In this episode, we explore evidence-based strategies for augmenting lithium when monotherapy fails in acute mania. Why is quetiapine the preferred add-on to valproate, despite decades of clinical tradition favoring anticonvulsants?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.

48 Listeners

73 Listeners

499 Listeners

143 Listeners

12,754 Listeners

2,512 Listeners

3,357 Listeners

156 Listeners

1,339 Listeners

10,243 Listeners

566 Listeners

471 Listeners

742 Listeners

193 Listeners

151 Listeners